Literature DB >> 25395424

von Willebrand factor is a cofactor in complement regulation.

Shuju Feng1, Xiaowen Liang2, Michael H Kroll1, Dominic W Chung3, Vahid Afshar-Kharghan1.   

Abstract

Several complement proteins interact with hemostatic factors. We discovered that von Willebrand factor (VWF) acts as a cofactor for factor I-mediated cleavage of complement C3b, thereby shutting down complement activation. The complement regulatory function of VWF multimers depends on their size. Smaller VWF multimers enhance cleavage of C3b but large and ultra-large VWF (ULVWF) multimers have no effect on C3b cleavage and permit default complement activation. We conclude that normal plasma VWF multimers prevent complement activation and steer the complement pathway toward generation of inactivated C3b (iC3b). ULVWF multimers, as are present in patients with thrombotic microangiopathy, lack an inhibitory effect on complement and permit complement activation.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25395424      PMCID: PMC4319234          DOI: 10.1182/blood-2014-06-585430

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

Authors:  Fengxiao Bu; Tara Maga; Nicole C Meyer; Kai Wang; Christie P Thomas; Carla M Nester; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

2.  Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

Authors:  Trung C Nguyen; Anne Liu; Li Liu; Chalmette Ball; Hiuwan Choi; William S May; Khatira Aboulfatova; Angela L Bergeron; Jing-Fei Dong
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

3.  Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

Authors:  Tomoko Ono; Jun Mimuro; Seiji Madoiwa; Kenji Soejima; Yuji Kashiwakura; Akira Ishiwata; Katsuhiro Takano; Tsukasa Ohmori; Yoichi Sakata
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

4.  Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor.

Authors:  Y P Wu; H H van Breugel; H Lankhof; R J Wise; R I Handin; P G de Groot; J J Sixma
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-05       Impact factor: 8.311

Review 5.  Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.

Authors:  Stephen J Perkins; Ruodan Nan; Keying Li; Sanaullah Khan; Ami Miller
Journal:  Immunobiology       Date:  2011-10-28       Impact factor: 3.144

Review 6.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

Review 7.  The factor H protein family.

Authors:  P F Zipfel; T S Jokiranta; J Hellwage; V Koistinen; S Meri
Journal:  Immunopharmacology       Date:  1999-05

8.  ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock.

Authors:  J A Kremer Hovinga; S Zeerleder; P Kessler; T Romani de Wit; J A van Mourik; C E Hack; H ten Cate; P H Reitsma; W A Wuillemin; B Lämmle
Journal:  J Thromb Haemost       Date:  2007-08-22       Impact factor: 5.824

9.  A new map of glycosaminoglycan and C3b binding sites on factor H.

Authors:  Christoph Q Schmidt; Andrew P Herbert; David Kavanagh; Carina Gandy; Christopher J Fenton; Bärbel S Blaum; Malcolm Lyon; Dusan Uhrín; Paul N Barlow
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

10.  Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.

Authors:  Nancy A Turner; Leticia Nolasco; Zaverio M Ruggeri; Joel L Moake
Journal:  Blood       Date:  2009-10-12       Impact factor: 22.113

View more
  25 in total

Review 1.  The complement system in COVID-19: friend and foe?

Authors:  Anuja Java; Anthony J Apicelli; M Kathryn Liszewski; Ariella Coler-Reilly; John P Atkinson; Alfred Hj Kim; Hrishikesh S Kulkarni
Journal:  JCI Insight       Date:  2020-08-06

2.  ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.

Authors:  Astrid Alflen; Steve Prüfer; Katharina Ebner; Sebastian Reuter; Pamela Aranda Lopez; Inge Scharrer; Fumiaki Banno; Michael Stassen; Hansjörg Schild; Kerstin Jurk; Markus Bosmann; Hendrik Beckert; Markus P Radsak
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

Review 3.  Atypical hemolytic uremic syndrome.

Authors:  Vahid Afshar-Kharghan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Von Willebrand factor regulates complement on endothelial cells.

Authors:  Damien G Noone; Magdalena Riedl; Fred G Pluthero; Mackenzie L Bowman; M Kathryn Liszewski; Lily Lu; Yi Quan; Steve Balgobin; Reinhard Schneppenheim; Sonja Schneppenheim; Ulrich Budde; Paula James; John P Atkinson; Nades Palaniyar; Walter H A Kahr; Christoph Licht
Journal:  Kidney Int       Date:  2016-05-25       Impact factor: 10.612

5.  P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.

Authors:  Nicolas S Merle; Romain Paule; Juliette Leon; Marie Daugan; Tania Robe-Rybkine; Victoria Poillerat; Carine Torset; Véronique Frémeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

Review 6.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

7.  Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy.

Authors:  Liang Zheng; Di Zhang; Wenjing Cao; Wen-Chao Song; X Long Zheng
Journal:  Blood       Date:  2019-08-13       Impact factor: 22.113

8.  Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.

Authors:  Saravanan Subramaniam; Kerstin Jurk; Lukas Hobohm; Sven Jäckel; Mona Saffarzadeh; Kathrin Schwierczek; Philip Wenzel; Florian Langer; Christoph Reinhardt; Wolfram Ruf
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

9.  Decreased severity of Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease.

Authors:  Matthew A Geramita; Johannes Hofer; James Cooper; Michael L Moritz
Journal:  BMJ Case Rep       Date:  2017-08-30

10.  Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.

Authors:  Danwen Qian; Hongliang Liu; Xiaomeng Wang; Jie Ge; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-12-08       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.